Evidence map›Paper›PMID 36065849›Full record

ArticlePhysiological reports2022

Can mobilization of bone marrow stem cells be an alternative regenerative therapy to stem cell injection in a rat model of chronic kidney disease?

Shereen Morsy, Mona F Mansour, Mohamed Abdo, Yasser El-Wazir

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Physiological reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shereen MorsyPhysiology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.ORCID 0000-0002-1066-4949
Mona F MansourPhysiology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.ORCID 0000-0002-8021-5348
Mohamed AbdoPhysiology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.ORCID 0000-0002-9969-7789
Yasser El-WazirPhysiology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.ORCID 0000-0003-4034-0213
Suez Canal University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is a priority health problem affecting 36% of Egyptians. Adipose-derived mesenchymal stem cells (ADMSCs) have multidifferentiation capacity and the ability to restore several types of cells including damaged renal cells. Granulocyte colony-stimulating factor (G-CSF) is known to mobilize hematopoietic stem cells from bone marrow to the peripheral circulation. The aim of this study was to compare the effect of endogenous CD34

Indexed as

Granulocyte Colony-Stimulating FactorHematopoietic Stem CellsHematopoietic Stem Cell TransplantationRenal Insufficiency, ChronicAlbuminsAnimalsBone Marrow CellsCreatinineDisease Models, AnimalDoxorubicinMaleRatsUreaAlbuminsCreatinineDoxorubicinGranulocyte Colony-Stimulating FactorUreaadipose tissue-derived mesenchymal stem cellsadriamycinCD34+ stem cellschronic kidney diseasegranulocyte colony-stimulating factormalondialdehyde

Identifiers

PMID36065849
PMCPMC9446404
OpenAlexW4294719149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.